Selected research
Industry Research
GMP Plasmid Service Industry Research Report 2026
Market perspective
The global GMP Plasmid Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the GMP Plasmid Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the GMP Plasmid Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the GMP Plasmid Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of GMP Plasmid Service include Aldevron, Andelyn Biosciences, Anemocyte, Catalent Biologics, Creative Biolabs, Esco Aster, VectorBuilder, Eurogentec and Pharmaron, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global GMP Plasmid Service market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to GMP Plasmid Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
GMP Plasmid Service Market by Company
Aldevron
Andelyn Biosciences
Anemocyte
Catalent Biologics
Creative Biolabs
Esco Aster
VectorBuilder
Eurogentec
Pharmaron
PlasmidFactory GmbH
ProBio CDMO
Sartorius
Takara Bio
GMP Plasmid Service Segment by Type
Plasmid for Viral Vector Production
Plasmid for Direct-Acting Therapeutics
Plasmid for In Vitro Transcription Template
Others
GMP Plasmid Service Segment by Application
Gene Therapy and Cell Therapy Industry
mRNA Vaccine and Therapy Industry
Diagnostic and Scientific Research Reagent Industry
Others
GMP Plasmid Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Plasmid Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Plasmid Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Plasmid Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of GMP Plasmid Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plasmid for Viral Vector Production
- Plasmid for Direct-Acting Therapeutics
- Plasmid for In Vitro Transcription Template
- Others
Applications
- Gene Therapy and Cell Therapy Industry
- mRNA Vaccine and Therapy Industry
- Diagnostic and Scientific Research Reagent Industry
- Others
Companies covered
- Aldevron
- Andelyn Biosciences
- Anemocyte
- Catalent Biologics
- Creative Biolabs
- Esco Aster
- VectorBuilder
- Eurogentec
- Pharmaron
- PlasmidFactory GmbH
- ProBio CDMO
- Sartorius
- Takara Bio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 GMP Plasmid Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Plasmid for Viral Vector Production
- 2.2.3 Plasmid for Direct-Acting Therapeutics
- 2.2.4 Plasmid for In Vitro Transcription Template
- 2.2.5 Others
- 2.3 GMP Plasmid Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Gene Therapy and Cell Therapy Industry
- 2.3.3 mRNA Vaccine and Therapy Industry
- 2.3.4 Diagnostic and Scientific Research Reagent Industry
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 GMP Plasmid Service Breakdown Data by Type
- 3.1 Global GMP Plasmid Service Historic Market Size by Type (2021-2026)
- 3.2 Global GMP Plasmid Service Forecasted Market Size by Type (2027-2032)
4 GMP Plasmid Service Breakdown Data by Application
- 4.1 Global GMP Plasmid Service Historic Market Size by Application (2021-2026)
- 4.2 Global GMP Plasmid Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global GMP Plasmid Service Market Perspective (2021-2032)
- 5.2 Global GMP Plasmid Service Growth Trends by Region
- 5.2.1 Global GMP Plasmid Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 GMP Plasmid Service Historic Market Size by Region (2021-2026)
- 5.2.3 GMP Plasmid Service Forecasted Market Size by Region (2027-2032)
- 5.3 GMP Plasmid Service Market Dynamics
- 5.3.1 GMP Plasmid Service Industry Trends
- 5.3.2 GMP Plasmid Service Market Drivers
- 5.3.3 GMP Plasmid Service Market Challenges
- 5.3.4 GMP Plasmid Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top GMP Plasmid Service Players by Revenue
- 6.1.1 Global Top GMP Plasmid Service Players by Revenue (2021-2026)
- 6.1.2 Global GMP Plasmid Service Revenue Market Share by Players (2021-2026)
- 6.2 Global GMP Plasmid Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of GMP Plasmid Service Head Office and Area Served
- 6.4 Global GMP Plasmid Service Players, Product Type & Application
- 6.5 Global GMP Plasmid Service Manufacturers Established Date
- 6.6 Global GMP Plasmid Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America GMP Plasmid Service Market Size (2021-2032)
- 7.2 North America GMP Plasmid Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America GMP Plasmid Service Market Size by Country (2021-2026)
- 7.4 North America GMP Plasmid Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe GMP Plasmid Service Market Size (2021-2032)
- 8.2 Europe GMP Plasmid Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe GMP Plasmid Service Market Size by Country (2021-2026)
- 8.4 Europe GMP Plasmid Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific GMP Plasmid Service Market Size (2021-2032)
- 9.2 Asia-Pacific GMP Plasmid Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific GMP Plasmid Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific GMP Plasmid Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America GMP Plasmid Service Market Size (2021-2032)
- 10.2 South America GMP Plasmid Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America GMP Plasmid Service Market Size by Country (2021-2026)
- 10.4 South America GMP Plasmid Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa GMP Plasmid Service Market Size (2021-2032)
- 11.2 Middle East & Africa GMP Plasmid Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa GMP Plasmid Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa GMP Plasmid Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Aldevron
- 12.1.1 Aldevron Company Information
- 12.1.2 Aldevron Business Overview
- 12.1.3 Aldevron Revenue in GMP Plasmid Service Business (2021-2026)
- 12.1.4 Aldevron GMP Plasmid Service Product Portfolio
- 12.1.5 Aldevron Recent Developments
- 12.2 Andelyn Biosciences
- 12.2.1 Andelyn Biosciences Company Information
- 12.2.2 Andelyn Biosciences Business Overview
- 12.2.3 Andelyn Biosciences Revenue in GMP Plasmid Service Business (2021-2026)
- 12.2.4 Andelyn Biosciences GMP Plasmid Service Product Portfolio
- 12.2.5 Andelyn Biosciences Recent Developments
- 12.3 Anemocyte
- 12.3.1 Anemocyte Company Information
- 12.3.2 Anemocyte Business Overview
- 12.3.3 Anemocyte Revenue in GMP Plasmid Service Business (2021-2026)
- 12.3.4 Anemocyte GMP Plasmid Service Product Portfolio
- 12.3.5 Anemocyte Recent Developments
- 12.4 Catalent Biologics
- 12.4.1 Catalent Biologics Company Information
- 12.4.2 Catalent Biologics Business Overview
- 12.4.3 Catalent Biologics Revenue in GMP Plasmid Service Business (2021-2026)
- 12.4.4 Catalent Biologics GMP Plasmid Service Product Portfolio
- 12.4.5 Catalent Biologics Recent Developments
- 12.5 Creative Biolabs
- 12.5.1 Creative Biolabs Company Information
- 12.5.2 Creative Biolabs Business Overview
- 12.5.3 Creative Biolabs Revenue in GMP Plasmid Service Business (2021-2026)
- 12.5.4 Creative Biolabs GMP Plasmid Service Product Portfolio
- 12.5.5 Creative Biolabs Recent Developments
- 12.6 Esco Aster
- 12.6.1 Esco Aster Company Information
- 12.6.2 Esco Aster Business Overview
- 12.6.3 Esco Aster Revenue in GMP Plasmid Service Business (2021-2026)
- 12.6.4 Esco Aster GMP Plasmid Service Product Portfolio
- 12.6.5 Esco Aster Recent Developments
- 12.7 VectorBuilder
- 12.7.1 VectorBuilder Company Information
- 12.7.2 VectorBuilder Business Overview
- 12.7.3 VectorBuilder Revenue in GMP Plasmid Service Business (2021-2026)
- 12.7.4 VectorBuilder GMP Plasmid Service Product Portfolio
- 12.7.5 VectorBuilder Recent Developments
- 12.8 Eurogentec
- 12.8.1 Eurogentec Company Information
- 12.8.2 Eurogentec Business Overview
- 12.8.3 Eurogentec Revenue in GMP Plasmid Service Business (2021-2026)
- 12.8.4 Eurogentec GMP Plasmid Service Product Portfolio
- 12.8.5 Eurogentec Recent Developments
- 12.9 Pharmaron
- 12.9.1 Pharmaron Company Information
- 12.9.2 Pharmaron Business Overview
- 12.9.3 Pharmaron Revenue in GMP Plasmid Service Business (2021-2026)
- 12.9.4 Pharmaron GMP Plasmid Service Product Portfolio
- 12.9.5 Pharmaron Recent Developments
- 12.10 PlasmidFactory GmbH
- 12.10.1 PlasmidFactory GmbH Company Information
- 12.10.2 PlasmidFactory GmbH Business Overview
- 12.10.3 PlasmidFactory GmbH Revenue in GMP Plasmid Service Business (2021-2026)
- 12.10.4 PlasmidFactory GmbH GMP Plasmid Service Product Portfolio
- 12.10.5 PlasmidFactory GmbH Recent Developments
- 12.11 ProBio CDMO
- 12.11.1 ProBio CDMO Company Information
- 12.11.2 ProBio CDMO Business Overview
- 12.11.3 ProBio CDMO Revenue in GMP Plasmid Service Business (2021-2026)
- 12.11.4 ProBio CDMO GMP Plasmid Service Product Portfolio
- 12.11.5 ProBio CDMO Recent Developments
- 12.12 Sartorius
- 12.12.1 Sartorius Company Information
- 12.12.2 Sartorius Business Overview
- 12.12.3 Sartorius Revenue in GMP Plasmid Service Business (2021-2026)
- 12.12.4 Sartorius GMP Plasmid Service Product Portfolio
- 12.12.5 Sartorius Recent Developments
- 12.13 Takara Bio
- 12.13.1 Takara Bio Company Information
- 12.13.2 Takara Bio Business Overview
- 12.13.3 Takara Bio Revenue in GMP Plasmid Service Business (2021-2026)
- 12.13.4 Takara Bio GMP Plasmid Service Product Portfolio
- 12.13.5 Takara Bio Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst